Two recently published studies identified several genes—BIK, SAMHD1, FAM111A, AOX1, among others—in which rare variants are significantly and strongly associated with increased risk of prostate cancer (PCa) and its aggressiveness [1, 2]. This evidence concerns the gene BIK and prostate carcinoma.